HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A Le Cesne Selected Research

Abdominal Fibromatosis

3/2010High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


A Le Cesne Research Topics

Disease

33Sarcoma (Soft Tissue Sarcoma)
11/2015 - 07/2000
12Neoplasms (Cancer)
11/2015 - 07/2000
4Neutropenia
01/2005 - 11/2000
3Liposarcoma
07/2015 - 03/2012
3Aggressive Fibromatosis (Desmoid)
01/2012 - 08/2010
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2014 - 07/2012
2Chondrosarcoma
11/2013 - 11/2013
1Hypertension (High Blood Pressure)
11/2015
1Chordoma
10/2015
1Disease Progression
07/2015
1Solitary Fibrous Tumors
01/2015
1Myxoid Liposarcoma
03/2012
1Weight Loss (Weight Reduction)
08/2011
1Breast Neoplasms (Breast Cancer)
05/2011
1Xeroderma Pigmentosum (Kaposi's Disease)
05/2011
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
01/2011
1Fibroma (Fibromatosis)
03/2010
1Abdominal Fibromatosis
03/2010
1Synovial Sarcoma (Synovioma)
03/2009
1Lymphopenia (Lymphocytopenia)
01/2003
1Sepsis (Septicemia)
11/2001
1Neoplasm Metastasis (Metastasis)
11/2001
1Anemia
11/2001
1Carcinoma (Carcinomatosis)
11/2001
1Ileus
11/2001
1Fever (Fevers)
11/2000

Drug/Important Bio-Agent (IBA)

8imatinib (Gleevec)FDA Link
09/2014 - 09/2003
7trabectedin (ecteinascidin 743)IBA
01/2015 - 01/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014 - 07/2000
3IfosfamideFDA LinkGeneric
06/2009 - 07/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2008 - 07/2005
2pazopanibIBA
11/2015 - 08/2012
2AnthracyclinesIBA
06/2009 - 11/2001
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2015
1Biological Markers (Surrogate Marker)IBA
11/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015
1sorafenib (BAY 43-9006)FDA Link
10/2015
1aplidineIBA
07/2015
1masitinibIBA
09/2014
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2014
1HhAntag691IBA
11/2013
1Investigational DrugsIBA
11/2013
1Phosphotransferases (Kinase)IBA
07/2012
1Messenger RNA (mRNA)IBA
05/2011
1ParaffinIBA
05/2011
1DNA (Deoxyribonucleic Acid)IBA
05/2011
1Biological FactorsIBA
08/2010
1beta CateninIBA
03/2010
1Melphalan (Alkeran)FDA LinkGeneric
04/2008
1TransaminasesIBA
01/2005
1thymidine 5'-triphosphate (TTP)IBA
09/2003
1Vindesine (Vindesin)IBA
11/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2002
1Mesna (Coenzyme M)FDA LinkGeneric
11/2002
1Dacarbazine (DIC)FDA LinkGeneric
11/2002
1Cisplatin (Platino)FDA LinkGeneric
11/2002
1TaxoidsIBA
11/2001
1vinorelbine (Navelbine)FDA LinkGeneric
11/2001
1tranilast (N 5')IBA
11/2001
1taxaneIBA
11/2001
1PlasticsIBA
05/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2000
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
07/2000

Therapy/Procedure

15Drug Therapy (Chemotherapy)
11/2013 - 07/2000
3Adjuvant Chemotherapy
12/2014 - 03/2009
3Adjuvant Radiotherapy
03/2013 - 09/2003
2Radiotherapy
12/2014 - 08/2011
2Salvage Therapy
02/2013 - 11/2001
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
08/2011
1Neoadjuvant Therapy
11/2006
1Hemipelvectomy
10/2006
1Limb Salvage
07/2005
1Free Tissue Flaps
05/2001